Literature DB >> 22012572

Over-expression of Sox2 in C3H10T1/2 cells inhibits osteoblast differentiation through Wnt and MAPK signalling pathways.

Daofang Ding1, Hao Xu, Qianqian Liang, Leqin Xu, Yongjian Zhao, Yongjun Wang.   

Abstract

PURPOSE: Many Sox proteins play important roles both in mesoderm and ectoderm development. It is reported that Sox2, a member of this family, is essential for the maintenance of the self-renewal of embryonic stem cells (ES) and neural stem cells (NSCs). To investigate whether Sox2 participates in mesoderm development besides ectoderm, Sox2 was introduced into C3H10T1/2 cells.
METHODS: We produced recombinant retrovirus expressing Sox2 in GP2-293t cells and infected the virus into C3H10T1/2 cells. Growth property, alkaline phosphatase (ALP) staining, mineralized nodules, osteogenic gene expression and related signal pathways were analysed and compared between Sox2-expressing cells and control cells.
RESULTS: Sox2 over-expression led to increased proliferation of C3H10T1/2 cells, activation of Wnt/β-catenin and p38MAPK pathways. When cultured in osteogenic differentiation medium, ALP and mineralized nodules formation were inhibited in Sox2 over-expressing cells with down-regulation of osteogenic gene expression as well as inhibition of Wnt/β-catenin and p38MAPK pathways.
CONCLUSIONS: All these data suggested that over-expression of Sox2 promoted proliferation and inhibited osteoblast differentiation of C3H10T1/2 cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22012572      PMCID: PMC3337101          DOI: 10.1007/s00264-011-1368-6

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  25 in total

1.  Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase.

Authors:  R K Jaiswal; N Jaiswal; S P Bruder; G Mbalaviele; D R Marshak; M F Pittenger
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

2.  Neural crest development is regulated by the transcription factor Sox9.

Authors:  Martin Cheung; James Briscoe
Journal:  Development       Date:  2003-10-01       Impact factor: 6.868

3.  Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex.

Authors:  Mizuho Tomioka; Masazumi Nishimoto; Satoru Miyagi; Tomoko Katayanagi; Nobutaka Fukui; Hitoshi Niwa; Masami Muramatsu; Akihiko Okuda
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

4.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.

Authors:  Haruhiko Akiyama; Marie-Christine Chaboissier; James F Martin; Andreas Schedl; Benoit de Crombrugghe
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

5.  The Sox2 high mobility group transcription factor inhibits mature osteoblast function in transgenic mice.

Authors:  Greg Holmes; Timothy G Bromage; Claudio Basilico
Journal:  Bone       Date:  2011-06-15       Impact factor: 4.398

6.  Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation.

Authors:  A Suzuki; J Guicheux; G Palmer; Y Miura; Y Oiso; J P Bonjour; J Caverzasio
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

7.  p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages.

Authors:  Xiaotong Li; Nobuyuki Udagawa; Masamichi Takami; Nobuaki Sato; Yasuhiro Kobayashi; Naoyuki Takahashi
Journal:  Endocrinology       Date:  2003-07-24       Impact factor: 4.736

8.  Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix.

Authors:  Chikahisa Higuchi; Akira Myoui; Nobuyuki Hashimoto; Kohji Kuriyama; Kiyoko Yoshioka; Hideki Yoshikawa; Kazuyuki Itoh
Journal:  J Bone Miner Res       Date:  2002-10       Impact factor: 6.741

9.  SOX2 functions to maintain neural progenitor identity.

Authors:  Victoria Graham; Jane Khudyakov; Pamela Ellis; Larysa Pevny
Journal:  Neuron       Date:  2003-08-28       Impact factor: 17.173

10.  Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation.

Authors:  Yuanyu Hu; Emily Chan; Sherry X Wang; Baojie Li
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

View more
  15 in total

1.  Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients.

Authors:  Bing Li; Zhiping Ge; Shipeng Song; Shengbin Zhang; Hong Yan; Boyun Huang; Yangde Zhang
Journal:  Pathol Oncol Res       Date:  2012-07-10       Impact factor: 3.201

2.  Elevated endothelial Sox2 causes lumen disruption and cerebral arteriovenous malformations.

Authors:  Jiayi Yao; Xiuju Wu; Daoqin Zhang; Lumin Wang; Li Zhang; Eric X Reynolds; Carlos Hernandez; Kristina I Boström; Yucheng Yao
Journal:  J Clin Invest       Date:  2019-06-24       Impact factor: 14.808

3.  Mitotic phosphorylation of SOX2 mediated by Aurora kinase A is critical for the stem-cell like cell maintenance in PA-1 cells.

Authors:  Dandan Qi; Qianqian Wang; Min Yu; Rongfeng Lan; Shuiming Li; Fei Lu
Journal:  Cell Cycle       Date:  2016-06-01       Impact factor: 4.534

4.  High Expression of SOX2 and OCT4 Indicates Radiation Resistance and an Independent Negative Prognosis in Cervical Squamous Cell Carcinoma.

Authors:  Liangfang Shen; Xinqiong Huang; Xiaoxue Xie; Juan Su; Jun Yuan; Xiang Chen
Journal:  J Histochem Cytochem       Date:  2014-04-07       Impact factor: 2.479

5.  Splicing factor TRA2B is required for neural progenitor survival.

Authors:  Jacqueline M Roberts; Hanane Ennajdaoui; Carina Edmondson; Brunhilde Wirth; Jeremy R Sanford; Bin Chen
Journal:  J Comp Neurol       Date:  2014-02-01       Impact factor: 3.215

6.  Evidence for Aryl hydrocarbon Receptor-Mediated Inhibition of Osteoblast Differentiation in Human Mesenchymal Stem Cells.

Authors:  AtLee T D Watson; Rachel C Nordberg; Elizabeth G Loboa; Seth W Kullman
Journal:  Toxicol Sci       Date:  2019-01-01       Impact factor: 4.849

7.  5-azacytidine improves the osteogenic differentiation potential of aged human adipose-derived mesenchymal stem cells by DNA demethylation.

Authors:  Xueying Yan; Sabrina Ehnert; Mihaela Culmes; Anastasia Bachmann; Claudine Seeliger; Lilianna Schyschka; Zhiyong Wang; Afshin Rahmanian-Schwarz; Ulrich Stöckle; Paul A De Sousa; Jaroslav Pelisek; Andreas K Nussler
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

8.  Marine sponge-derived smenospongine preferentially eliminates breast cancer stem-like cells via p38/AMPKα pathways.

Authors:  Jie Tang; Wei Wu; Fan Yang; Liyun Liu; Zhen Yang; Li Liu; Weizhuo Tang; Fan Sun; Houwen Lin
Journal:  Cancer Med       Date:  2018-07-07       Impact factor: 4.452

9.  Regulation of osteoblast behaviors via cross-talk between Hippo/YAP and MAPK signaling pathway under fluoride exposure.

Authors:  Wen-Qing Zhu; Ying-Juan Yu; Li-Na Xu; Pan-Pan Ming; Shui-Yi Shao; Jing Qiu
Journal:  J Mol Med (Berl)       Date:  2019-05-04       Impact factor: 4.599

10.  MiR-103 alleviates autophagy and apoptosis by regulating SOX2 in LPS-injured PC12 cells and SCI rats.

Authors:  Guowei Li; Tao Chen; Yingxian Zhu; Xiaoyu Xiao; Juyuan Bu; Zongwen Huang
Journal:  Iran J Basic Med Sci       Date:  2018-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.